Clinical Trial Update: Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery [Phase 3]

View source ↗

Summary

This document reports the completion and results posting of a Phase 3 trial evaluating apixaban for prevention of thrombosis-related events following knee repla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Deep Vein Thrombosis, Pulmonary Embolism | Phase 3 | Status: COMPLETED | Results posted: 2015-12-30